Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP418911.RAJs2dUfbT3yORcIDc49Wckw1pBCH4qx_0P0RHcrzYHS8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418911.RAJs2dUfbT3yORcIDc49Wckw1pBCH4qx_0P0RHcrzYHS8130_assertion type Assertion NP418911.RAJs2dUfbT3yORcIDc49Wckw1pBCH4qx_0P0RHcrzYHS8130_head.
- NP418911.RAJs2dUfbT3yORcIDc49Wckw1pBCH4qx_0P0RHcrzYHS8130_assertion description "[Specifically, methylation of IGSF4 and DAPK1 was prevalent in SCC (75% and 75% of cases, respectively) and HSIL (59% and 71%, respectively) but was absent in LSIL and normal biopsy samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418911.RAJs2dUfbT3yORcIDc49Wckw1pBCH4qx_0P0RHcrzYHS8130_provenance.
- NP418911.RAJs2dUfbT3yORcIDc49Wckw1pBCH4qx_0P0RHcrzYHS8130_assertion evidence source_evidence_literature NP418911.RAJs2dUfbT3yORcIDc49Wckw1pBCH4qx_0P0RHcrzYHS8130_provenance.
- NP418911.RAJs2dUfbT3yORcIDc49Wckw1pBCH4qx_0P0RHcrzYHS8130_assertion SIO_000772 16166431 NP418911.RAJs2dUfbT3yORcIDc49Wckw1pBCH4qx_0P0RHcrzYHS8130_provenance.
- NP418911.RAJs2dUfbT3yORcIDc49Wckw1pBCH4qx_0P0RHcrzYHS8130_assertion wasDerivedFrom befree-20140225 NP418911.RAJs2dUfbT3yORcIDc49Wckw1pBCH4qx_0P0RHcrzYHS8130_provenance.
- NP418911.RAJs2dUfbT3yORcIDc49Wckw1pBCH4qx_0P0RHcrzYHS8130_assertion wasGeneratedBy ECO_0000203 NP418911.RAJs2dUfbT3yORcIDc49Wckw1pBCH4qx_0P0RHcrzYHS8130_provenance.